BioSpace News Archive

The 2018 Healthcare Supplier Diversity Symposium convenes in Chicago in September

Acquisition furthers Astellas’ commitment to innovation in ophthalmology with addition of novel gene therapy program for glaucoma

PBI-4050 reduces the activation of hepatic stellate cells, the major cells involved in liver fibrosis

Canopy Growth Corporation and its wholly owned subsidiary Spectrum Cannabis, together with Dr. Danial Schecter, Co-founder of the Cannabinoid Medical Clinic, today announced a new Catalyst Peer Mentorship Program

REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced the pricing of an underwritten public offering of 2,700,000 shares of its common stock at the price of $65.00 per share before underwriting discounts and commissions.

Array BioPharma, Inc. today announced that Carrie S. Cox has been named Chairman of its Board of Directors, effective immediately.

Eiger BioPharmaceuticals, Inc. announced today financial results for the three and six months ended June 30, 2018 and provided a business update.

Following Severe 2017-2018 Flu Season, Rite Aid Certified Immunizing Pharmacists Encourage Vaccination Across All Age Groups

ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe, today announced the completion of recruitment of 52 patients for the phase 2 part of its global phase 2/3 study investigating varlitinib as first line therapy in HER1/HER2 co-expressing advanced or metastatic gastric cancer patients.

MYM Nutraceuticals Inc. is pleased to announce the appointment of Elizabeth S. Liu, QC to the Board of Directors effective August 1, 2018.